Growth hormone axis in patients with chronic kidney disease

Hormones (Athens). 2019 Mar;18(1):71-73. doi: 10.1007/s42000-018-0066-9. Epub 2018 Sep 25.

Authors

Stavroula A Paschou^{1

2}, Christina Kanaka-Gantenbein¹, George P Chrousos¹, Andromachi Vryonidou³

Affiliations

¹ Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, "Aghia Sophia" Children's Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
² Department of Endocrinology and Diabetes, Hellenic Red Cross Hospital, Athanasaki 1, 11526, Athens, Greece.
³ Department of Endocrinology and Diabetes, Hellenic Red Cross Hospital, Athanasaki 1, 11526, Athens, Greece. mahi_vr@hotmail.com.

PMID: 30255481
DOI: 10.1007/s42000-018-0066-9

No abstract available

Publication types

Editorial

MeSH terms

Child
Female
Growth Disorders / drug therapy
Growth Disorders / etiology
Growth Disorders / metabolism*
Human Growth Hormone / administration & dosage
Human Growth Hormone / metabolism*
Humans
Insulin-Like Growth Factor I / metabolism*
Male
Renal Insufficiency, Chronic / complications
Renal Insufficiency, Chronic / metabolism*

Substances

IGF1 protein, human
Human Growth Hormone
Insulin-Like Growth Factor I